|
Name |
Cytochalasin Z28
|
| Molecular Formula | C30H37NO6 | |
| IUPAC Name* |
(1S,5E,8S,10E,12S,13S,15S,17S)-13-hydroxy-17-[(4-hydroxyphenyl)methyl]-6,8,15-trimethyl-14-propan-2-ylidene-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-5,10-diene-3,7,19-trione
|
|
| SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C(C)C)[C@H](C3[C@]2(C(=O)N[C@H]3CC4=CC=C(C=C4)O)OC(=O)C/C=C(/C1=O)\C)C)O
|
|
| InChI |
InChI=1S/C30H37NO6/c1-16(2)25-19(5)26-23(15-20-10-12-21(32)13-11-20)31-29(36)30(26)22(28(25)35)8-6-7-17(3)27(34)18(4)9-14-24(33)37-30/h6,8-13,17,19,22-23,26,28,32,35H,7,14-15H2,1-5H3,(H,31,36)/b8-6+,18-9+/t17-,19+,22-,23-,26?,28-,30+/m0/s1
|
|
| InChIKey |
WNLXIJVAWRHENW-XNAJFPMCSA-N
|
|
| Synonyms |
Cytochalasin Z28
|
|
| CAS | NA | |
| PubChem CID | 139588560 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 507.6 | ALogp: | 3.3 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 113.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 37 | QED Weighted: | 0.402 |
| Caco-2 Permeability: | -4.776 | MDCK Permeability: | 0.00005990 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.981 |
| Human Intestinal Absorption (HIA): | 0.05 | 20% Bioavailability (F20%): | 0.007 |
| 30% Bioavailability (F30%): | 0.007 |
| Blood-Brain-Barrier Penetration (BBB): | 0.613 | Plasma Protein Binding (PPB): | 98.79% |
| Volume Distribution (VD): | 0.79 | Fu: | 2.36% |
| CYP1A2-inhibitor: | 0.046 | CYP1A2-substrate: | 0.085 |
| CYP2C19-inhibitor: | 0.421 | CYP2C19-substrate: | 0.421 |
| CYP2C9-inhibitor: | 0.549 | CYP2C9-substrate: | 0.087 |
| CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.096 |
| CYP3A4-inhibitor: | 0.912 | CYP3A4-substrate: | 0.385 |
| Clearance (CL): | 11.032 | Half-life (T1/2): | 0.058 |
| hERG Blockers: | 0.095 | Human Hepatotoxicity (H-HT): | 0.41 |
| Drug-inuced Liver Injury (DILI): | 0.86 | AMES Toxicity: | 0.007 |
| Rat Oral Acute Toxicity: | 0.636 | Maximum Recommended Daily Dose: | 0.941 |
| Skin Sensitization: | 0.168 | Carcinogencity: | 0.434 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
| Respiratory Toxicity: | 0.982 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003672 | ![]() |
0.743 | D0S2BV | ![]() |
0.265 | ||
| ENC004801 | ![]() |
0.612 | D06XZW | ![]() |
0.264 | ||
| ENC001865 | ![]() |
0.593 | D0S0LZ | ![]() |
0.233 | ||
| ENC004119 | ![]() |
0.466 | D0FX2Q | ![]() |
0.232 | ||
| ENC004372 | ![]() |
0.446 | D04UTT | ![]() |
0.226 | ||
| ENC002183 | ![]() |
0.444 | D0SP3D | ![]() |
0.225 | ||
| ENC002622 | ![]() |
0.431 | D09NNH | ![]() |
0.225 | ||
| ENC004371 | ![]() |
0.430 | D0V3ZA | ![]() |
0.224 | ||
| ENC002161 | ![]() |
0.423 | D0Q0PR | ![]() |
0.222 | ||
| ENC005176 | ![]() |
0.420 | D01XDL | ![]() |
0.221 | ||